Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study

Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study

Pituitary carcinoma is an aggressive tumor characterized by metastatic spread beyond the sellar region. Symptoms can be debilitating due to hormonal excess and survival is poor. Pituitary carcinomas recur despite conventional multimodality treatments. Given the recent advances in the use of immune c...

Full description

Saved in:
Bibliographic Details
Main Authors: Siqing Fu, Aung Naing, Filip Janku, Mingxuan Xu, Anas Alshawa, Nazanin Majd, Steven G Waguespack, Marta Penas-Prado, Carlos Kamiya-Matsuoka, Shaan M Raza, Ian E McCutcheon
Format: Article
Language:English
Published: BMJ Publishing Group 2020-10-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/2/e001532.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items